Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | heat shock protein HSP90 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Trypanosoma brucei | heat shock protein 90, putative | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0335 | 0.2019 | 0.655 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0335 | 0.2019 | 0.655 |
Brugia malayi | heat shock protein 90 | 0.0421 | 0.3082 | 1 |
Trypanosoma brucei | Heat shock protein 83, putative | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Treponema pallidum | heat shock protein 90 | 0.0335 | 0.2019 | 0.5 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0421 | 0.3082 | 1 |
Plasmodium vivax | heat shock protein 86, putative | 0.0421 | 0.3082 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0421 | 0.3082 | 1 |
Trypanosoma cruzi | Heat shock protein 83, putative | 0.0421 | 0.3082 | 1 |
Echinococcus granulosus | heat shock protein | 0.0421 | 0.3082 | 1 |
Echinococcus multilocularis | heat shock protein 90 | 0.0421 | 0.3082 | 0.3082 |
Mycobacterium leprae | PROBABLE CHAPERONE PROTEIN HTPG (HEAT SHOCK PROTEIN) (HSP90 FAMILY PROTEIN) (HIGH TEMPERATURE PROTEIN G) | 0.0335 | 0.2019 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | heat shock protein 90 | 0.0335 | 0.2019 | 0.5 |
Loa Loa (eye worm) | heat shock protein 90 | 0.0421 | 0.3082 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0335 | 0.2019 | 0.655 |
Plasmodium falciparum | heat shock protein 90 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Trichomonas vaginalis | endoplasmin, putative | 0.0258 | 0.1063 | 0.345 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Toxoplasma gondii | heat shock protein 90, putative | 0.0421 | 0.3082 | 1 |
Plasmodium vivax | endoplasmin, putative | 0.0421 | 0.3082 | 1 |
Loa Loa (eye worm) | endoplasmin | 0.0421 | 0.3082 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.0397 | 0.1289 |
Trichomonas vaginalis | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0258 | 0.1063 | 0.345 |
Schistosoma mansoni | heat shock protein | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Schistosoma mansoni | endoplasmin | 0.0421 | 0.3082 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0249 | 0.0942 | 0.3058 |
Echinococcus multilocularis | endoplasmin | 0.0335 | 0.2019 | 0.2019 |
Echinococcus multilocularis | heat shock protein | 0.0421 | 0.3082 | 0.3082 |
Schistosoma mansoni | heat shock protein | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0421 | 0.3082 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0335 | 0.2019 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Mycobacterium ulcerans | heat shock protein 90 | 0.0335 | 0.2019 | 0.5 |
Echinococcus granulosus | heat shock protein heat shock protein 90 alpha | 0.0335 | 0.2019 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Onchocerca volvulus | Heat shock protein 75 kDa, mitochondrial homolog | 0.0173 | 0 | 0.5 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0421 | 0.3082 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0397 | 0.0397 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Plasmodium falciparum | endoplasmin, putative | 0.0258 | 0.1063 | 0.345 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Echinococcus multilocularis | heat shock protein 90 | 0.0335 | 0.2019 | 0.2019 |
Trichomonas vaginalis | heat shock protein, putative | 0.0335 | 0.2019 | 0.655 |
Trypanosoma brucei | heat shock protein 90, putative | 0.0421 | 0.3082 | 1 |
Leishmania major | lipophosphoglycan biosynthetic protein, putative,heat shock protein 90, putative,glucose regulated protein 94, putative | 0.0335 | 0.2019 | 0.655 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0397 | 0.1289 |
Echinococcus granulosus | heat shock protein 90 | 0.0421 | 0.3082 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Echinococcus granulosus | endoplasmin | 0.0335 | 0.2019 | 0.655 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0421 | 0.3082 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0397 | 0.1289 |
Echinococcus granulosus | heat shock protein 90 | 0.0335 | 0.2019 | 0.655 |
Trypanosoma brucei | heat shock protein, putative | 0.0421 | 0.3082 | 1 |
Schistosoma mansoni | endoplasmin | 0.0421 | 0.3082 | 1 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.0421 | 0.3082 | 1 |
Brugia malayi | Endoplasmin precursor | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0421 | 0.3082 | 1 |
Mycobacterium tuberculosis | Probable chaperone protein HtpG (heat shock protein) (HSP90 family protein) (high temperature protein G) | 0.0335 | 0.2019 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.2589 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.575 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.